NASDAQ:CADL
Candel Therapeutics, Inc.
- Stock
industry
Biotechnologyexchange
NASDAQ Global Marketwebsite
www.candeltx.comipo date
Jul 23, 2021full time employees
76currency
USD
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prosta...Show More
Earnings
Earnings Release in 6 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus